BRIEF published on 05/28/2026 at 19:11, 3 days 11 hours ago ABIONYX Pharma: Review of the first quarter of 2026 Revenue Treasury Funding Innovative Therapies Sepsis
BRIEF published on 05/28/2026 at 19:11, 3 days 11 hours ago ABIONYX Pharma Reports Stable First Quarter and Robust Financing for Future Growth Clinical Trials Capital Increase Financial Stability ABIONYX Pharma Revenue 2026
PRESS RELEASE published on 05/28/2026 at 19:06, 3 days 11 hours ago Inside Information / Other news releases ABIONYX Pharma updates its operations and cash position for Q1 2026. Consolidated revenue of €0.8M, cash reserves of €2.8M. Funding secured till 2028 through capital increase and non-dilutive loan Revenue Cash Position Funding ABIONYX Pharma Q1 2026
PRESS RELEASE published on 05/27/2026 at 07:30, 4 days 23 hours ago Inside Information / Other news releases ABIONYX Pharma launches a fully secured capital increase with preferential subscription rights and structured debt financing for up to EUR 33M. Finnja Capital commits EUR 10M in a non-dilutive loan Capital Increase Preferential Subscription Rights ABIONYX Pharma Fenja Capital Structured Debt Financing
BRIEF published on 04/08/2026 at 23:59, 1 month 22 days ago ABIONYX Reports Share Capital and Voting Rights Details Euronext Paris Share Capital Voting Rights Financial Disclosure ABIONYX
PRESS RELEASE published on 04/08/2026 at 23:54, 1 month 22 days ago Inside Information / Other news releases ABIONYX Pharma releases monthly statement of total voting rights and shares for March 31, 2026, in accordance with French regulations Shares French Regulations Total Voting Rights Biotech Company ABIONYX Pharma
BRIEF published on 03/17/2026 at 19:31, 2 months 14 days ago ABIONYX Pharma makes available the 2025 Universal Registration Document AMF Biopharmaceutical Registration Document ABIONYX Pharma Sepsis
PRESS RELEASE published on 03/17/2026 at 19:26, 2 months 14 days ago Inside Information / Other news releases ABIONYX Pharma announces the availability of its Universal Registration Document for the year 2025, filed with the AMF and accessible on their website AMF Biopharmaceutical Universal Registration Document ABIONYX Pharma Sepsis
BRIEF published on 03/03/2026 at 19:40, 2 months 28 days ago ABIONYX: Information on voting rights and shares as of February 28, 2026 Euronext Paris Share Capital Voting Rights AMF ABIONYX
BRIEF published on 03/03/2026 at 19:40, 2 months 28 days ago ABIONYX Announces February Voting Rights Update Euronext Paris Voting Rights AMF Regulations ABIONYX Pharma February 2026
Published on 05/30/2026 at 04:00, 2 days 3 hours ago Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
Published on 05/30/2026 at 02:40, 2 days 4 hours ago BEACN Announces Financial Results for the First Quarter of 2026 and Update on Loan
Published on 05/30/2026 at 01:30, 2 days 5 hours ago Core Critical Approved for Listing on OTCQB(R) Venture Market
Published on 05/30/2026 at 00:31, 2 days 6 hours ago Gold Basin Resources Provides Updates on Arrangement with CANEX
Published on 05/29/2026 at 23:00, 2 days 8 hours ago The Fresh Factory Reports Q1 2026 Financial Results with 17% Billed Revenue Growth, Completes New Facility Retrofit
Published on 06/01/2026 at 06:15, 46 minutes ago Embracing a Zero-Carbon Future | The 6th LiuGong Global Customer Day Held in Liuzhou
Published on 05/31/2026 at 00:15, 1 day 6 hours ago Take Your Shot & Make Your Moment: OPPO Ignites Football Culture with Technology at the UEFA Champions League Final
Published on 05/30/2026 at 19:35, 1 day 11 hours ago THE KILLERS ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
Published on 05/30/2026 at 17:10, 1 day 13 hours ago MakerWorld's First User-Initiated Charity Contest Names Winners, Bringing Global Creators' Goodwill Directly to Cancer Wards
Published on 06/01/2026 at 06:59, 2 minutes ago OPmobility and Yanfeng finalize the strengthening of their Chinese joint venture YFPO
Published on 05/29/2026 at 22:00, 2 days 9 hours ago Information on the Annual Financial Statements 2025
Published on 05/29/2026 at 18:00, 2 days 13 hours ago Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 12:00, 2 days 19 hours ago Capital increase through exercise of subscription rights
